Private Dinner
Biopharma has leveraged AI in Discovery for some time, with its potential now attracting billions in investment across all lines of business. The challenge is how to differentiate hype from reality, and ensure the investments can be operationalised. Join us for an evening discussion to gain insights and share experiences regarding these fast moving innovations.
Key Takeaways
Advance operational efficiency and accelerate time to market.
Focus on safety and pharmacovigilance to safeguard your most valuable asset—the patient.
Optimise research and development by enhancing experiment management and throughput.
Ensure product quality and streamline manufacturing processes.
Strengthen regulatory operations through improved internal monitoring of tasks.
